The first electrochemical quadruple immunoplatform for the simultaneous determination of RF, anti-PAD4, anti-MCV, and anti-CCP antibodies—all of them relevant biomarkers of rheumatoid arthritis (RA)—is reported in this paper. The gene discussed is PADI4; the disease is rheumatoid arthritis.